Commentary

Bringing a new drug to market now takes, on average, $2.6 billion and more than 10 years. Those numbers could shrink, and countless patients could benefit, if Food and Drug Administration regulators were less risk-averse. I know that from firsthand experience. Oct. 30 marks the 36th...

By Hank Campbell and Henry I. Miller A recent op-ed harangue in the Washington Post — "Scientists know plastics are dangerous. Why won't the government say so? — by radical activist Paul Thacker seeks to create concern about the health effects of plastics and plasticizers.  It reads like a cross between...

Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is...

This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine. To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients...

Four U.S. cities just sued President Trump for failing to faithfully execute the Affordable Care Act. The governments of Baltimore, Chicago, Cincinnati and Columbus accuse the Trump administration of "waging a relentless campaign to sabotage" Obamacare by cutting its advertising budget, shortening the open enrollment period and ending some...